sorafenib has been researched along with isoquinoline in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (isoquinoline) | Trials (isoquinoline) | Recent Studies (post-2010) (isoquinoline) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 397 | 0 | 211 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HJ; Choi, HS; Choi, JH; El-Gamal, MI; Kim, G; Lee, SH; Oh, CH; Sim, T; Yoo, KH | 1 |
1 other study(ies) available for sorafenib and isoquinoline
| Article | Year |
|---|---|
Novel quinolinylaminoisoquinoline bioisosteres of sorafenib as selective RAF1 kinase inhibitors: design, synthesis, and antiproliferative activity against melanoma cell line.
Topics: Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Isoquinolines; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Sorafenib; Structure-Activity Relationship | 2013 |